“…Of the qualifying trials containing human genes in major BP regulatory pathways, we extracted 11 genes associated with the BP response to exercise under criteria 1 [33,34,35,36,37,38,39,40]; 18 genes associated with hypertension in GWAS under criteria 2 [41,42,43,44,45,46,47,48]; 28 genes associated with the BP response to pharmacotherapy under criteria 3 [49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70]; 27 genes associated with physical activity and/or obesity in GWAS under criteria 4a [71,72,73,74,75,76,77,78,79,80,81,82,83,84,85]; and 29 genes associated with BP, physical activity, and/or obesity in non-GWAS under criteria 4b [86,87,88] displayed in Supplemental Digital Content (SDC) 1 Table S1. In addition, we included the 41 genes from our preliminary work that were reported to be associated with hypertension or the BP response to exercise or pharmacotherapy [27,28,29].…”